HCPCS Level II drug code
J9050 — Injection, carmustine, 100 mg
In short
J9050 is the HCPCS Level II code for injection, carmustine, 100 mg. CMS assigns NDCs for Bicnu and Carmustine to it. One billing unit is 100 mg. The Medicare Part B payment limit is $195.73 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, carmustine, 100 mg
- Short descriptor
- Carmustine injection
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2009
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 100 mg. For example, 10000 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J9050
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 11 NDCs to J9050 for Bicnu and Carmustine. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Bicnu | 23155-0261-41 | Heritage Pharmaceuticals Inc. | 1 | 1 |
| Carmustine | 00781-3474-32 | Sandoz Inc. | 1 | 1 |
| Carmustine | 23155-0649-41 | Heritage Pharmaceuticals Inc. | 1 | 1 |
| Carmustine | 23155-0790-41 | Heritage Pharmaceuticals Inc. | 1 | 1 |
| Carmustine | 43598-0628-57 | Dr. Reddy's Laboratories Inc. | 1 | 1 |
| Carmustine | 62332-0659-02 | Alembic Pharmaceuticals Inc. | 1 | 1 |
| Carmustine | 70121-1482-02 | Amneal Pharmaceuticals, LLC | 1 | 1 |
| Carmustine | 70710-1525-09 | Zydus Pharmaceuticals (USA) Inc. | 1 | 1 |
| Carmustine | 70860-0223-61 | Athenex Pharmaceutical Division, LLC | 1 | 1 |
| Carmustine | 71288-0126-90 | Meitheal Pharmaceuticals Inc. | 1 | 1 |
| Carmustine | 72205-0198-01 | Novadoz Pharmaceuticals LLC | 1 | 1 |
J9050: common questions
- Is J9050 a CPT code?
- No. J9050 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J9050?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 11 NDCs under J9050, for Bicnu and Carmustine. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J9050?
- $195.73 per 100 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J9050?
- One unit of J9050 is 100 mg, as stated in the code's descriptor. Units to report = dose given ÷ 100 mg. J-code billing units.